Triaziquone

This classification denotes an ethylenimine compound with the molecular formula C12H13N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F3D5D9P25I, chemically known as 2,3,5-tris-ethyleniminoquinone-(1,4) but more generally known as triaziquone, which bears US NIH Compound Identifier 6235. European Medicines Agency schedules Triaziquone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11257MIG. The term TRIAZIQUONE is an International Non-Proprietary Name. World Health Organization schedules triaziquone in its Anatomical Therapeutic Chemical (ATC) Classification. TRIAZIQUONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule triaziquone under HS 29339990 and SITC 51577. As of Q4 2014, TRIAZIQUONE remains US FDA's Preferred Term for this commodity. Triaziquone bears US NLM identifiers UMLS ID C0040878 and NCI Concept Code C903. SMILES: C1CN1C2=CC(=O)C(=C(C2=O)N3CC3)N4CC4.